ABBV-3373 is an anti-TNF antibody-drug conjugate (ADC). ABBV-3373 is composed of humanized TNF antibody Adalimumab and glucocorticoid receptor agonist. ABBV-3373 can be used in the study of rheumatoid arthritis.

Physicochemical Properties

Storage	Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Shipping Condition	Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity

References

[1]. Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate. J Med Chem. 2022 Dec 8;65(23):15893-15934.

Solubility Data